Fig. 5From: Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarkerVerification of ANGPTL6 in animals and human samples. a General picture and western blot analysis of ANGPTL6 in Sprague Dawley rat model and human samples. b Representative images of H&E staining (top) and immunohistochemistry staining for ANGPTL6 (bottom), from human normal liver tissue, HCC tumor, and its peritumoral tissues. Scale bar, 100 μm. Data were expressed as mean with SEM. Statistical analysis was performed by Mann–Whitney test. **P < 0.01 vs Normal or Control, ###P < 0.001 vs adjacent. HCC, hepatocellular carcinomaBack to article page